Page v. Purdue Pharma Headquarters

CourtDistrict Court, D. New Mexico
DecidedDecember 27, 2019
Docket1:19-cv-00944
StatusUnknown

This text of Page v. Purdue Pharma Headquarters (Page v. Purdue Pharma Headquarters) is published on Counsel Stack Legal Research, covering District Court, D. New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Page v. Purdue Pharma Headquarters, (D.N.M. 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO

WILFRED ALEXANDER PAGE,

Plaintiff,

v. No. 1:19-cv-00944-WJ-SCY

PURDUE PHARMA HEADQUARTERS, et al.

Defendants.

MEMORANDUM OPINION AND ORDER OF DISMISSAL AND TO SHOW CAUSE

THIS MATTER comes before the Court on Plaintiff’s Complaint and Request for Injunction, Doc. 6, filed November 12, 2019 (“Amended Complaint”). Dismissal of Proceedings In Forma Pauperis Plaintiff is proceeding in forma pauperis. See Order Granting Application to Proceed In Forma Pauperis, Doc. 5, filed November 6, 2019. The statute governing proceedings in forma pauperis states "the court shall dismiss the case at any time if the court determines that . . . the action . . . fails to state a claim on which relief may be granted." 28 U.S.C. § 1915(e)(2); see also Webb v. Caldwell, 640 Fed.Appx. 800, 802 (10th Cir. 2016) ("We have held that a pro se complaint filed under a grant of ifp can be dismissed under § 1915(e)(2)(B)(ii) for failure to state a claim . . . only where it is obvious that the plaintiff cannot prevail on the facts he has alleged and it would be futile to give him an opportunity to amend"). The Court notified Plaintiff that the Complaint fails to state a claim because it fails to state with particularity what each Defendant did to Plaintiff: While the Complaint alleges that Defendant Purdue Pharma "played a key role" and "lack[ed] transparency," “conclusory allegations without supporting factual averments are insufficient to state a claim on which relief can be based . . . [and] in analyzing the sufficiency of the plaintiff's complaint, the court need accept as true only the plaintiff's well-pleaded factual contentions, not his conclusory allegations.” Hall v. Bellmon, 935 F.2d 1106, 1110 (10th Cir. 1991). There are no factual allegations regarding the other Defendants.

Order at 4, Doc. 5, filed November 6, 2019. The Court explained to Plaintiff that: A complaint must "give the defendant fair notice of what the . . . claim is and the grounds upon which it rests." Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 555 (2007). The Complaint must "make clear exactly who is alleged to have done what to whom, to provide each individual with fair notice." Robbins v. Oklahoma, 519 F.3d 1242, 1249-50 (10th Cir. 2008) (emphasis in original); see also Nasious v. Two Unknown B.I.C.E. Agents, at Arapahoe County Justice Center, 492 F.3d 1158, 1163 (10th Cir. 2007) (“[T]o state a claim in federal court, a complaint must explain what each defendant did to him or her; when the defendant did it; how the defendant’s action harmed him or her; and, what specific legal right the plaintiff believes the defendant violated.”) (emphasis added).

and granted Plaintiff leave to file an amended complaint. Doc. 5 at 3-4. The Court dismisses this case because Plaintiff’s Amended Complaint fails to state a claim. Despite the Court’s explanation that a complaint must state with particularity what each Defendant did to Plaintiff, there are no factual allegations in the Amended Complaint regarding the named Defendants. Instead, the Amended Complaint states the events giving rise to Plaintiff’s claims occurred with “Every Global Citizen receiving Medical RX’s from Purdue Pharma” from “1892-Current Date,” and that: my Genome is the most advanced super human genome to date in which [unnamed] doctors alter my medical records in an attempt to publish me and my findings while not adhering to their care of treatment plan and under medicating me to try to gain access to my genome for their own selfish reasons case in question [Plaintiff] Wilfred Alexander Page (Medical Doctor Dr, Roger Gildersleeve) from his own misunderstandings of how and what drugs are how they are classified and how they work in a persons system.

[sic] Amended Complaint at 5. The Amended Complaint fails to state a claim against the named Defendants and against Dr. Gildersleeve and the unnamed doctors because it does not explain what each named Defendant and doctors did to Plaintiff; when the they did it; how each Defendant’s action harmed Plaintiff; and, what specific legal right Plaintiff believes they violated. Court’s Power to Impose Filing Restrictions The Court of Appeals for the Tenth Circuit has discussed the Court’s power to impose filing restrictions and the procedure for imposing filing restrictions:

“[T]he right of access to the courts is neither absolute nor unconditional and there is no constitutional right of access to the courts to prosecute an action that is frivolous or malicious.” Tripati v. Beaman, 878 F.2d 351, 353 (10th Cir.1989) (per curiam) (citation omitted). “There is strong precedent establishing the inherent power of federal courts to regulate the activities of abusive litigants by imposing carefully tailored restrictions under the appropriate circumstances.” Cotner v. Hopkins, 795 F.2d 900, 902 (10th Cir.1986). “Even onerous conditions may be imposed upon a litigant as long as they are designed to assist the ... court in curbing the particular abusive behavior involved,” except that they “cannot be so burdensome ... as to deny a litigant meaningful access to the courts.” Id. (brackets and internal quotation marks omitted). “Litigiousness alone will not support an injunction restricting filing activities. However, injunctions are proper where the litigant's abusive and lengthy history is properly set forth.” Tripati, 878 F.2d at 353 (citations omitted). “[T]here must be some guidelines as to what [a party] must do to obtain the court's permission to file an action.” Id. at 354. “In addition, [the party] is entitled to notice and an opportunity to oppose the court's order before it is instituted.” Id. A hearing is not required; a written opportunity to respond is sufficient. See id.

Landrith v. Schmidt, 732 F.3d 1171, 1174 (10th Cir. 2013). Litigant’s Abusive History Plaintiff has filed eight cases in this Court since late August, 2019. See Page v. Central New Mexico Treatment Center, 1:19-cv-00762-MV-SCY (dismissed for lack of subject matter jurisdiction); Page v. Albuquerque Municipal Mental Health Court, 1:19-cv-00763-JAP-JHR (dismissed for lack of subject matter jurisdiction; Plaintiff failed to timely supplement his complaint after being notified by the Court that he failed to state precisely the relief he was seeking); Page v. Albuquerque Metro Detention Center, 1:19-cv-00924-WJ-SCY (dismissed for failure to state a claim; after the Court notified Plaintiff that his original complaint failed to state a claim, explained what he needed to allege to state a claim, and granting Plaintiff leave to file an amended complaint, Plaintiff filed an amended complaint that similarly failed to state a claim); Page v. Albuquerque Police Department, 1:19-cv-00925-JB-JFR (pending; the Magistrate Judge notified Plaintiff that the complaint failed to state a claim and granted Plaintiff leave to file an amended complaint); Page v. University of New Mexico, 1:19-cv-00926-RB-JHR (dismissed for

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Nasious v. Two Unknown B.I.C.E. Agents
492 F.3d 1158 (Tenth Circuit, 2007)
Anant Kumar Tripati v. William C. Beaman
878 F.2d 351 (Tenth Circuit, 1989)
Webb v. Caldwell
640 F. App'x 800 (Tenth Circuit, 2016)
DePineda v. Hemphill
34 F.3d 946 (Tenth Circuit, 1994)
Landrith v. Schmidt
732 F.3d 1171 (Tenth Circuit, 2013)
Cotner v. Hopkins
795 F.2d 900 (Tenth Circuit, 1986)
Hall v. Bellmon
935 F.2d 1106 (Tenth Circuit, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
Page v. Purdue Pharma Headquarters, Counsel Stack Legal Research, https://law.counselstack.com/opinion/page-v-purdue-pharma-headquarters-nmd-2019.